Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate

NCT02284880 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: BIA 2-093
DRUG: BIA 2-093

Sponsor

Bial - Portela C S.A.